---
title: "Ozempic (semaglutide) in type 2 diabetes: Indication questions"
description: "Indication questions on Ozempic (semaglutide) in type 2 diabetes, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is Ozempic approved for? What is the generic name of Ozempic? Is Ozempic approved for weight loss? 3 questions quoted from 4 sources."
canonical: "https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/indication"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ozempic (semaglutide) in type 2 diabetes: Indication questions

Manufacturer: Novo Nordisk Inc.  
Prescribing information: [Ozempic](https://www.novo-pi.com/ozempic.pdf), [Ozempic tablets](https://www.novo-pi.com/ozempictablets.pdf)

## Indication

<a id="ozempic-indications"></a>

### What is Ozempic approved for?

> “Ozempic<sup>®</sup> (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic<sup>®</sup> (semaglutide) tablets 4 mg or 9 mg are indicated:
>
> as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
>
> Ozempic<sup>®</sup> injection is indicated:
>
> to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease
> to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
>
> Ozempic<sup>®</sup> tablets are indicated:
>
> to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events”

Source: [OZEMPIC: GLP-1 RA for T2D, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic.html#:~:text=%28semaglutide%29%20injection%200.5%20mg%2C%201%20mg%2C%20or%202%20mg%20and,high%20risk%20for%20these%20events)

<a id="ozempic-weight-loss"></a>

### Is Ozempic approved for weight loss?

> “Ozempic<sup>®</sup> is not indicated for weight loss.”

Source: [OZEMPIC: GLP-1 RA for T2D, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic.html#:~:text=is%20not%20indicated%20for%20weight%20loss.)

> “While the primary endpoint in the majority of clinical trials was mean change in A1C, mean change in body weight was generally evaluated as a confirmatory secondary endpoint.<sup>1,2</sup>”

Source: [OZEMPIC: FAQs, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic/about/frequently-asked-questions.html#:~:text=While%20the%20primary%20endpoint%20in,evaluated%20as%20a%20confirmatory%20secondary)

This passage is in a collapsed section of the page; select: Will Ozempic® help my patients lose weight?

## Drug names

<a id="ozempic-generic-name"></a>

### What is the generic name of Ozempic?

> “OZEMPIC<sup>®</sup> (semaglutide) injection, for subcutaneous use, contains semaglutide, a human GLP-1 
> receptor agonist (or GLP-1 analog).”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

> “RYBELSUS<sup>®</sup> and OZEMPIC<sup>®</sup> tablets, for oral use, contain semaglutide, a GLP-1 receptor agonist.”

Source: [OZEMPIC: Ozempic®, page 6, captured 2026-11-12](https://www.novo-pi.com/ozempictablets.pdf#page=6)

Note: The first passage is from the Ozempic® injection Prescribing Information; the second is from the Prescribing Information for semaglutide tablets.

## Related pages
- [Medical information: Ozempic (semaglutide): Type 2 diabetes](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes)
- [Pharmacology](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/safety)
- [Specific populations](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/access-and-coverage)
